102 related articles for article (PubMed ID: 3775769)
1. Coronary dilator effect of MCI-176, a new calcium channel blocker, in dogs.
Horii D; Ishibashi A
Tohoku J Exp Med; 1986 Sep; 150(1):101-2. PubMed ID: 3775769
[TBL] [Abstract][Full Text] [Related]
2. Effect of MCI-176, a new calcium channel blocker, on large and small coronary arteries in dogs.
Ishibashi T; Nakazawa M; Imai S
Cardiovasc Res; 1989 Apr; 23(4):295-302. PubMed ID: 2590912
[TBL] [Abstract][Full Text] [Related]
3. Collateral blood flow following acute coronary artery occlusion: comparison of a new intracellular calcium antagonist (KT-362) and diltiazem.
Farber NE; Gross GJ
J Cardiovasc Pharmacol; 1989 Jul; 14(1):66-72. PubMed ID: 2475718
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamics and coronary flow following diltiazem administration in anesthetized dogs and in humans.
Bourassa MG; Cote P; Theroux P; Tubau JF; Genain C; Waters DD
Chest; 1980 Jul; 78(1 Suppl):224-30. PubMed ID: 7398410
[TBL] [Abstract][Full Text] [Related]
5. The effect of diltiazem on the coronary haemodynamic and cardiac functional effects produced by intracoronary administration of endothelin-1 in the anaesthetized dog.
Nichols AJ; Koster PF; Ohlstein EH
Br J Pharmacol; 1990 Mar; 99(3):597-601. PubMed ID: 2184913
[TBL] [Abstract][Full Text] [Related]
6. Effects of MCI-176, a new quinazolinone calcium antagonist, on myocardial energy and carbohydrate metabolism in ischemic dog hearts.
Abe Y; Ichihara K; Abiko Y
Biochem Pharmacol; 1991 Feb; 41(3):445-51. PubMed ID: 1825270
[TBL] [Abstract][Full Text] [Related]
7. Vasodilator action of KB-944, a new calcium antagonist.
Morita T; Yoshino K; Kanazawa T; Ito K; Nose T
Arzneimittelforschung; 1982; 32(9):1037-42. PubMed ID: 6890822
[TBL] [Abstract][Full Text] [Related]
8. Effect of MCI-176, a new calcium antagonist, on the calcium induced contraction of isolated porcine coronary arteries.
Ishibashi A; Horii D
Jpn J Pharmacol; 1987 Feb; 43(2):234-6. PubMed ID: 3573428
[TBL] [Abstract][Full Text] [Related]
9. Effects of 3'-angeloyloxy-4'-acetoxy-3',4'-dihydroseselin on cardiohemodynamics in anesthetized dogs.
Chang TH; Adachi H; Okuyama T; Mori N; Saito I; Zhang KY; Sun XD; Li JM
Zhongguo Yao Li Xue Bao; 1994 Nov; 15(6):507-10. PubMed ID: 7709748
[TBL] [Abstract][Full Text] [Related]
10. Coronary hemodynamics following intravenous or intracoronary injection of diltiazem in man.
Bertrand ME; Dupuis BA; Lablanche JM; Tilmant PY; Thieuleux FA
J Cardiovasc Pharmacol; 1982; 4(5):695-9. PubMed ID: 6182397
[TBL] [Abstract][Full Text] [Related]
11. The hemodynamic effects of lacidipine in anesthetized dogs: comparison with nitrendipine, amlodipine, verapamil, and diltiazem.
Quartaroli M; Gambini F; Tarter G; Micheli D; Trist DG; Gaviraghi G
J Cardiovasc Pharmacol; 1991 Sep; 18(3):326-36. PubMed ID: 1720831
[TBL] [Abstract][Full Text] [Related]
12. Coronary vasodilator versus cardiac effects of MCI-176, a novel quinazolinone calcium antagonist, in the dog heart.
Hosono M; Taira N
J Cardiovasc Pharmacol; 1987 Jun; 9(6):633-40. PubMed ID: 2442528
[TBL] [Abstract][Full Text] [Related]
13. The effect of diltiazem on coronary flow reserve in humans.
Rossen JD; Simonetti I; Marcus ML; Braun P; Winniford MD
Circulation; 1989 Nov; 80(5):1240-6. PubMed ID: 2805261
[TBL] [Abstract][Full Text] [Related]
14. Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms.
Millard RW; Lathrop DA; Grupp G; Ashraf M; Grupp IL; Schwartz A
Am J Cardiol; 1982 Feb; 49(3):499-506. PubMed ID: 6277175
[TBL] [Abstract][Full Text] [Related]
15. Effect of diltiazem on experimental coronary artery thrombosis in dogs.
Schumacher WA; Lucchesi BR
Pharmacology; 1990; 41(1):16-23. PubMed ID: 2236203
[TBL] [Abstract][Full Text] [Related]
16. Myocardial perfusion distal to an acute or chronic coronary artery occlusion: effects of diltiazem and nifedipine.
Zyvoloski MG; Brooks HL; Gross GJ; Warltier DC
J Pharmacol Exp Ther; 1982 Aug; 222(2):494-500. PubMed ID: 7097568
[TBL] [Abstract][Full Text] [Related]
17. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
[TBL] [Abstract][Full Text] [Related]
18. Effects of intravenous diltiazem on cardiocirculatory dynamics and cardiac output distribution in conscious spontaneously hypertensive rats.
Flaim SF; Newman ED; Annibali JA
J Cardiovasc Pharmacol; 1986; 8(2):241-51. PubMed ID: 2422460
[TBL] [Abstract][Full Text] [Related]
19. MCl-176, a novel calcium channel blocker, attenuates the ischemic myocardial acidosis induced by coronary artery occlusion in dogs.
Hara Y; Ichihara K; Abiko Y
J Pharmacol Exp Ther; 1988 Apr; 245(1):305-10. PubMed ID: 3361449
[TBL] [Abstract][Full Text] [Related]
20. Voltage- and use-dependent block of the inward calcium current by MCI-176, a new non-dihydropyridine calcium antagonist, in canine ventricular muscles and single ventricular cells of the guinea-pig.
Iijima T; Takahashi K; Taira N
Jpn J Pharmacol; 1988 Feb; 46(2):155-64. PubMed ID: 2454341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
